Latest News about AMGN
Recent news which mentions AMGN
3 Must-Own Dividend Stocks in This Chaotic Market
December 06, 2021
From Motley Fool
A Peek Into The Markets: US Stock Futures Mostly Higher; Crude Oil Up 2%
December 06, 2021
From Benzinga
5 Stocks To Watch For December 6, 2021
December 06, 2021
From Benzinga
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
From Benzinga
Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks of 2021?
December 02, 2021
From Motley Fool
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
From Benzinga
Janssen's Subcutaneous Darzalex Combo Wins FDA Approval For Pretreated Multiple Myeloma
December 02, 2021
From Benzinga
Amgen's Otezla Meets Primary Goal In Late-Stage Genital Psoriasis Study
December 02, 2021
Tickers
AMGN
From Benzinga
2 Ridiculously Cheap Dividend Stocks To Buy for 2022
December 01, 2021
From Motley Fool
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
From InvestorPlace
Bristol Myers' Deucravacitinib Under FDA Review For Plaque Psoriasis
November 29, 2021
From Benzinga
3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
November 28, 2021
From Motley Fool
10 Biggest Price Target Changes For Monday
November 22, 2021
From Benzinga
1 Cancer Stock on Buyout Watch in 2022
November 21, 2021
From Motley Fool
2 Dividend Stocks to Buy Right Now
November 19, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
3 Pharma Stocks That Could Make You Richer in November (and Beyond)
November 12, 2021
From Motley Fool
Here Are the Highlights From Amgen's Q3 Results
November 11, 2021
From Motley Fool
The Key Behind Vertex's Great Q3 Results
November 11, 2021
From Motley Fool
3 Nasdaq Stocks to Buy and Hold for Years
November 10, 2021
From InvestorPlace
Making a Difference When You Invest? Medexus Says It Improves Lives
November 10, 2021
From Benzinga
This Company Says Its New Topical Therapy Trials Bringing Hope to People Exposed to Biofilm Bacteria
November 09, 2021
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
2 Incredibly Cheap Dividend Stocks to Buy Now
November 03, 2021
From Motley Fool
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.